FDA outlines expanded efforts to reduce animal testing in drug development after reporting significant first-year progress under its roadmap to modernize nonclinical studies, with upcoming steps focused on scaling alternative methods, improving data infrastructure, and tightening global coordination.
President Trump signs an executive order aimed at accelerating the development and availability of psychedelic-based treatments for patients with serious mental illness.
FDA outlines expanded efforts to reduce animal testing in drug development after reporting significant first-year progress under its roadmap to modernize nonclinical studies, with upcoming steps focused on scaling alternative methods, improving data infrastructure, and tightening global coordination.
President Trump signs an executive order aimed at accelerating the development and availability of psychedelic-based treatments for patients with serious mental illness.
FDA accepts for priority review a Pfizer and Astellas Pharma supplemental BLA for Padcev (enfortumab vedotin-ejfv) that seeks to expand its use for patients with muscle-invasive bladder cancer.
FDA clears a Philips 510(k) for its new Spectral CT Verida system, which the company describes as the first AI-powered detector-based spectral CT scanner.
